SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-046425
Filing Date
2018-02-15
Accepted
2018-02-15 07:03:12
Documents
100
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d503767d10k.htm 10-K 1200107
2 EX-10.37 d503767dex1037.htm EX-10.37 30452
3 EX-23.1 d503767dex231.htm EX-23.1 2317
4 EX-31.1 d503767dex311.htm EX-31.1 9567
5 EX-31.2 d503767dex312.htm EX-31.2 9586
6 EX-32.1 d503767dex321.htm EX-32.1 5378
13 GRAPHIC g503767g08s72.jpg GRAPHIC 58058
  Complete submission text file 0001193125-18-046425.txt   6731973

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vnda-20171231.xml EX-101.INS 1190724
8 XBRL TAXONOMY EXTENSION SCHEMA vnda-20171231.xsd EX-101.SCH 79618
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnda-20171231_cal.xml EX-101.CAL 100198
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnda-20171231_def.xml EX-101.DEF 457146
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnda-20171231_lab.xml EX-101.LAB 590190
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnda-20171231_pre.xml EX-101.PRE 542884
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 18616091
SIC: 2834 Pharmaceutical Preparations